FDMT vs MOS · rev $37.0K vs P/E 161, rev $11.12B
4D Molecular Therapeutics Inc (FDMT) versus The Mosaic Company (MOS) — a side-by-side from cached financials, not a winner call.
4D Molecular Therapeutics Inc (FDMT) is a biotechnology company listed on US.
The Mosaic Company (MOS) is a agricultural inputs company listed on US.
Latest reported FDMT revenue for 2024-12-31 was $37.0K. Net income was -$160.9M. Revenue was down 99.8% from 2023-12-31 to 2024-12-31. FDMT currently screens at market cap $518.1M.
Latest reported MOS revenue for 2024-12-31 was $11.12B. Net income was $202.0M. Revenue was down 18.8% from 2023-12-31 to 2024-12-31. MOS currently screens at market cap $7.15B and trailing P/E 160.8.
FDMT currently screens at market cap $518.1M. MOS currently screens at market cap $7.15B and trailing P/E 160.8.
Not investment advice. Open the FDMT and MOS stock pages for the full models.
Not investment advice.